Test
Back to all Representative Matters
Jun 22, 2020

MediPharm Labs Completes $37.8 Million Private Placement

Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins

MediPharm Labs Corp. (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor (the “Investor”) for aggregate gross proceeds of $37,822,500 (the “Offering”).

On June 8, 2020, MediPharm Labs completed the Offering pursuant to which $18,911,250 was related to the placement of a $20.5 million unsecured convertible note and a warrant to purchase up to 3,601,427 common shares of the Company (the “Common Shares”); and $18,911,250 of which is currently being held in escrow and is related to the placement of a subscription receipt entitling the holder to receive, upon satisfaction of certain escrow release conditions, a further $20.5 million unsecured convertible note and a further warrant to purchase up to 3,601,427 Common Shares.

Aird & Berlis LLP represented MediPharm Labs with a team comprised of Melanie Cole, Amy Marcen-Gaudaur and Meredith McCann (capital markets), and Aaron Collins (financial services).

Related Industries

Related Representative Matters

Representative Matters
Allied Properties REIT Acquires Urban Office Portfolio for $794 Million Margaret T. Nelligan, Melanie Cole, Marek Lorenc, Amy Marcen-Gaudaur, Meredith McCann, Michael D. Smith, Leonard Baranek, J. Kyle Genga, Ethan Eisen, Rachel D. Rice, Barbara Worndl, Angelo Gentile and Aaron Collins Apr 06, 2022 On March 31, 2022, Allied Properties Real Estate Investment Trust, a leading operator of distinct... On March 31, 2022, Allied Properties Real Estate Investment Trust, a leading operator of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, completed the acquisition of six urban office properties from Choice Properties Real Estate Inv...
Representative Matters
SQI Diagnostics Acquires Precision Biomonitoring’s Human Diagnostic Testing Business Marek Lorenc, Liam Tracey-Raymont, Ryan Cohen, Al Turnbull, Francesco Gucciardo, Angelo Gentile, Kyle B. Plunkett and Jose Garcia-Bonilla Feb 23, 2022 On February 14, 2022, SQI Diagnostics Inc., a leader in the science of lung health that develops ... On February 14, 2022, SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision medical tests, completed the acquisition of the assets underlying Precision Biomonitoring Inc.’s human diagnostic COVID-19 PCR...
Representative Matters
Waygar Capital Completes $30 Million Financing Aaron Collins Sep 16, 2021 Waygar Capital, as agent for Ninepoint Canadian Senior Debt Fund, completed its $30,000,000 finan... Waygar Capital, as agent for Ninepoint Canadian Senior Debt Fund, completed its $30,000,000 financing of Enterprise Group Inc., a specialized equipment rental and services organization to Canada's energy sector, to fund asset purchases, enhance capital expenditures and diversify acquisition strat...